ArticlesM&A Healthcare Advisors2024-04-16T23:10:38-07:00

News & Articles

A Clinical Consultant’s Role in Healthcare M&A

M&A Healthcare Advisors2024-07-15T18:58:53-07:00July 16th, 2024|

The Role of a Financial Consultant in a Sell-side Process

M&A Healthcare Advisors2024-07-09T10:29:36-07:00July 9th, 2024|

The Role of Legal Support in a Sell-side Process

M&A Healthcare Advisors2024-08-20T16:22:33-07:00June 25th, 2024|

Video: How Do We Increase a Seller’s Leverage and Drive Value?

M&A Healthcare Advisors2024-07-11T09:05:17-07:00June 22nd, 2024|

The Full Potential of a Dedicated Transaction Team

M&A Healthcare Advisors2024-08-20T16:22:54-07:00June 11th, 2024|

How Much Will it Cost to Sell My Healthcare Business?

M&A Healthcare Advisors2024-05-28T11:41:18-07:00May 28th, 2024|

Navigating the Impact of Medicaid’s 80/20 Rule on Home Care M&A Trends

M&A Healthcare Advisors2024-05-22T05:43:29-07:00May 22nd, 2024|

Understanding Value Based on EBITDA Multiples

M&A Healthcare Advisors2024-05-24T07:05:36-07:00May 14th, 2024|

Insights On Walmart’s Shift From Andre Ulloa

M&A Healthcare Advisors2024-05-08T09:38:53-07:00May 8th, 2024|

Demystifying EBITDA and its Relationship to Valuation

Jennifer Orechwa2024-05-05T12:58:45-07:00April 29th, 2024|

Big M&A Questions, Part Three: “What Is My Healthcare Company Worth?

Jennifer Orechwa2024-04-20T23:58:47-07:00April 5th, 2024|

Big M&A Questions, Part Two: Who is Likely to Acquire My Business?

Jennifer Orechwa2024-05-24T06:19:57-07:00April 5th, 2024|

Big M&A Questions, Part One: “Why Do I Need an Advisor?”

Jennifer Orechwa2024-04-20T23:59:09-07:00April 5th, 2024|

Walgreens’ Setback and VillageMD’s Clinic Closures: What Does It Mean?

M&A Healthcare Advisors2024-05-08T08:07:18-07:00April 3rd, 2024|

Deciphering the Health Clinic Market: Insights from M&A Advisors

M&A Healthcare Advisors2024-05-08T08:07:25-07:00March 30th, 2024|

2024 Brings New Scrutiny and Oversight to Healthcare M&A

Jennifer Orechwa2024-04-13T00:33:32-07:00March 7th, 2024|

M&A Healthcare Advisors: Looking Ahead to 2024

Jennifer Orechwa2024-04-12T23:14:09-07:00February 15th, 2024|

M&A Healthcare Advisors 2023 End Of Year Review

Jennifer Orechwa2024-04-12T23:14:46-07:00January 24th, 2024|

Understanding the Risks of the 36-Month Rule in Hospice Transactions

M&A Healthcare Advisors2024-04-13T00:36:03-07:00December 7th, 2023|

Analyzing the Shifts in Home Health and Hospice Market: Insights from M&A Healthcare Advisors

M&A Healthcare Advisors2024-04-13T00:37:24-07:00November 30th, 2023|

The Durability of Specialty Pharmacy

M&A Healthcare Advisors2024-04-13T00:45:10-07:00November 2nd, 2023|

Private Equity’s Growing Interest in Home Healthcare

M&A Healthcare Advisors2024-04-13T00:47:58-07:00October 12th, 2023|

Episode 7: Understanding Transactional Accounting And Why It’s Necessary (Part Three)

M&A Healthcare Advisors2024-08-19T13:26:11-07:00October 4th, 2023|

Episode 6: Understanding Transactional Accounting And Why It’s Necessary (Part Two)

M&A Healthcare Advisors2024-08-19T13:27:02-07:00October 3rd, 2023|

M&A Healthcare Advisors Named To 2023 Axial Advisor 100 Group

M&A Healthcare Advisors2024-04-13T00:49:47-07:00September 27th, 2023|